Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CAH Cardinal Health	$155.97 +0.5%	$159.74	$96.05 ▼ $168.44	$37.23B	0.67	1.63 million shs	1.59 million shs
COR Cencora	$288.31 +0.8%	$292.97	$218.65 ▼ $309.35	$55.45B	0.57	941,703 shs	1.14 million shs
HSIC Henry Schein	$67.98 +0.5%	$71.62	$60.56 ▼ $82.49	$8.23B	0.82	1.62 million shs	1.56 million shs
MCK McKesson	$698.43 +0.7%	$716.58	$464.42 ▼ $737.89	$86.77B	0.5	561,144 shs	960,996 shs

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CAH Cardinal Health	+0.56%	-0.72%	-3.65%	+4.26%	+54.70%
COR Cencora	+0.78%	-0.64%	-0.95%	-1.32%	+21.24%
HSIC Henry Schein	+0.49%	-4.87%	-8.73%	+4.10%	-5.50%
MCK McKesson	+0.70%	-1.88%	-1.03%	-1.25%	+13.19%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CAH Cardinal Health	4.8 of 5 stars	2.4	4.0	4.2	3.6	3.1	1.7	2.5
COR Cencora	4.406 of 5 stars	2.4	2.0	3.3	3.1	3.6	3.3	1.3
HSIC Henry Schein	4.2355 of 5 stars	3.2	2.0	0.0	3.4	3.3	1.7	1.9
MCK McKesson	4.546 of 5 stars	1.4	5.0	3.3	3.0	3.0	2.5	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CAH Cardinal Health	2.79	Moderate Buy	$158.07	1.35% Upside
COR Cencora	2.75	Moderate Buy	$309.83	7.47% Upside
HSIC Henry Schein	2.33	Hold	$78.08	14.86% Upside
MCK McKesson	2.86	Moderate Buy	$710.17	1.68% Upside

Current Analyst Ratings Breakdown

Latest COR, MCK, CAH, and HSIC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/25/2025	HSIC Henry Schein	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$80.00 ➝ $75.00
7/16/2025	CAH Cardinal Health	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$181.00 ➝ $190.00
7/16/2025	COR Cencora	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Equal Weight ➝ Equal Weight	$313.00 ➝ $330.00
7/16/2025	MCK McKesson	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$770.00 ➝ $810.00
7/14/2025	HSIC Henry Schein	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$75.00
7/14/2025	HSIC Henry Schein	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
7/14/2025	HSIC Henry Schein	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Neutral	$82.00 ➝ $72.00
7/9/2025	HSIC Henry Schein	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	In-Line ➝ In-Line	$72.00 ➝ $78.00
7/9/2025	MCK McKesson	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$760.00 ➝ $800.00
6/30/2025	COR Cencora	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$275.00 ➝ $300.00
6/13/2025	CAH Cardinal Health	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Overweight ➝ Overweight	$166.00 ➝ $181.00

(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CAH Cardinal Health	$222.29B	0.17	$10.59 per share	14.73	($13.19) per share	-11.82
COR Cencora	$638.56M	87.51	$20.04 per share	14.39	$4.04 per share	71.36
HSIC Henry Schein	$12.67B	0.65	$7.37 per share	9.23	$32.33 per share	2.10
MCK McKesson	$359.05B	0.24	$39.13 per share	17.85	($13.52) per share	-51.66

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CAH Cardinal Health	$852M	$6.41	24.33	17.43	1.54	0.70%	-68.84%	4.21%	8/12/2025 (Estimated)
COR Cencora	$1.51B	$8.62	33.45	17.08	1.42	0.55%	344.71%	4.26%	8/6/2025 (Confirmed)
HSIC Henry Schein	$390M	$3.20	21.24	13.54	2.19	3.21%	14.87%	5.82%	8/5/2025 (Estimated)
MCK McKesson	$3.30B	$25.83	27.04	19.06	1.40	0.92%	-201.12%	5.83%	8/6/2025 (Estimated)

Latest COR, MCK, CAH, and HSIC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2025	Q4 2025	CAH Cardinal Health	$2.03	N/A	N/A	N/A	$60.91 billion	N/A
8/6/2025	Q3 2025	COR Cencora	$3.79	N/A	N/A	N/A	$80.34 billion	N/A
8/6/2025	Q1 2026	MCK McKesson	$8.33	N/A	N/A	N/A	$95.93 billion	N/A
8/5/2025	Q2 2025	HSIC Henry Schein	$1.19	N/A	N/A	N/A	$3.22 billion	N/A
5/8/2025	Q4 2025	MCK McKesson	$9.83	$10.12	+$0.29	$10.01	$94.00 billion	$90.82 billion
5/7/2025	Q2 2025	COR Cencora	$4.07	$4.42	+$0.35	$3.68	$75.41 billion	$75.50 billion
5/5/2025	Q1 2025	HSIC Henry Schein	$1.11	$1.15	+$0.04	$0.88	$3.24 billion	$3.17 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CAH Cardinal Health	$2.04	1.31%	N/A	31.83%	29 Years
COR Cencora	$2.20	0.76%	N/A	25.52%	15 Years
HSIC Henry Schein	N/A	N/A	N/A	N/A	N/A
MCK McKesson	$2.84	0.41%	N/A	10.99%	17 Years

Latest COR, MCK, CAH, and HSIC Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/30/2025	MCK McKesson	quarterly	$0.82	0.46%	9/2/2025	9/2/2025	10/1/2025
5/5/2025	CAH Cardinal Health	quarterly	$0.5107	1.35%	7/1/2025	7/1/2025	7/15/2025
5/8/2025	COR Cencora	quarterly	$0.55	0.8%	5/16/2025	5/16/2025	6/2/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CAH Cardinal Health	N/A	0.94	0.50
COR Cencora	6.01	0.87	0.52
HSIC Henry Schein	0.50	1.38	0.75
MCK McKesson	N/A	0.90	0.53

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CAH Cardinal Health	87.17%
COR Cencora	97.52%
HSIC Henry Schein	96.62%
MCK McKesson	85.07%

Insider Ownership

Company	Insider Ownership
CAH Cardinal Health	0.09%
COR Cencora	10.80%
HSIC Henry Schein	1.08%
MCK McKesson	0.08%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CAH Cardinal Health	48,900	238.68 million	238.46 million	Optionable
COR Cencora	46,000	193.82 million	172.89 million	Optionable
HSIC Henry Schein	25,000	121.72 million	120.41 million	Optionable
MCK McKesson	45,000	125.11 million	125.01 million	Optionable

COR, MCK, CAH, and HSIC Headlines

Recent News About These Companies

McKesson Corporation (MCK) Announces Results of Annual Shareholder Meeting

August 1 at 10:42 AM | gurufocus.com

Unlocking Q1 Potential of McKesson (MCK): Exploring Wall Street Estimates for Key Metrics

August 1 at 10:16 AM | zacks.com

McKesson Holds Annual Shareholders Meeting, Key Decisions Made

August 1 at 9:51 AM | tipranks.com

McKesson Corporation (NYSE:MCK) Shares Sold by Empirical Financial Services LLC d.b.a. Empirical Wealth Management

August 1 at 6:36 AM | marketbeat.com

First National Trust Co Reduces Stock Position in McKesson Corporation (NYSE:MCK)

August 1 at 5:54 AM | marketbeat.com

McKesson Corporation (NYSE:MCK) Shares Acquired by Federated Hermes Inc.

August 1 at 5:23 AM | marketbeat.com

Blueshift Asset Management LLC Takes $900,000 Position in McKesson Corporation (NYSE:MCK)

August 1 at 4:37 AM | marketbeat.com

McKesson Corporation (NYSE:MCK) Shares Bought by Castellan Group

August 1 at 4:26 AM | marketbeat.com

McKesson Corporation (NYSE:MCK) Stock Position Trimmed by Commerce Bank

August 1 at 4:26 AM | marketbeat.com

Lynwood Price Capital Management LP Acquires 9,200 Shares of McKesson Corporation (NYSE:MCK)

August 1 at 4:15 AM | marketbeat.com

MGO One Seven LLC Has $2.80 Million Stock Holdings in McKesson Corporation (NYSE:MCK)

August 1 at 4:15 AM | marketbeat.com

Arkadios Wealth Advisors Buys 2,292 Shares of McKesson Corporation (NYSE:MCK)

August 1 at 4:05 AM | marketbeat.com

Why McKesson (MCK) Dipped More Than Broader Market Today

July 31 at 6:50 PM | zacks.com

McKesson Corporation (NYSE:MCK) Raises Dividend to $0.82 Per Share

July 31 at 9:14 AM | marketbeat.com

McKesson (MCK) Expected to Announce Quarterly Earnings on Wednesday

July 31 at 7:06 AM | marketbeat.com

McKesson Corporation (NYSE:MCK) Shares Sold by Foster & Motley Inc.

July 31 at 6:30 AM | marketbeat.com

McKesson Raises Quarterly Dividend by 15%

July 30 at 1:15 PM | marketwatch.com

McKesson (MCK) Earnings Expected to Grow: Should You Buy?

July 30 at 11:08 AM | zacks.com

McKesson raises quarterly dividend by 15.5% to $0.82/share

July 30 at 8:14 AM | msn.com

McKesson raises quarterly dividend by 15.5% to $0.82/share

July 30 at 8:04 AM | seekingalpha.com

McKesson Corporation Raises Quarterly Dividend by 15% to $0.82 Per Share

July 30 at 8:00 AM | businesswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

NVDA Greenlight: China H20 Sales Spark 50% Rally Potential
By Thomas Hughes | July 15, 2025
View NVDA Greenlight: China H20 Sales Spark 50% Rally Potential
Forget the Weak Dollar—These 3 Travel Stocks Are Still Taking Off
By Chris Markoch | July 6, 2025
View Forget the Weak Dollar—These 3 Travel Stocks Are Still Taking Off
Palantir Gets Price Hike From Wedbush Amid High Valuation
By Chris Markoch | July 15, 2025
View Palantir Gets Price Hike From Wedbush Amid High Valuation
AI Infrastructure Is Exploding—Don’t Overlook CoreWeave & Nebius
By Jeffrey Neal Johnson | July 17, 2025
View AI Infrastructure Is Exploding—Don’t Overlook CoreWeave & Nebius
CrowdStrike Scores Big With Gartner, But Valuation Is Stretched
By Chris Markoch | July 25, 2025
View CrowdStrike Scores Big With Gartner, But Valuation Is Stretched

COR, MCK, CAH, and HSIC Company Descriptions

Cardinal Health NYSE:CAH

$155.97 +0.75 (+0.48%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$156.22 +0.25 (+0.16%)

As of 08/1/2025 07:32 PM Eastern

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Cencora NYSE:COR

$288.31 +2.23 (+0.78%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$288.70 +0.38 (+0.13%)

As of 08/1/2025 06:20 PM Eastern

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Henry Schein NASDAQ:HSIC

$67.98 +0.33 (+0.49%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$67.98 +0.00 (+0.01%)

As of 08/1/2025 04:20 PM Eastern

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

McKesson NYSE:MCK

$698.43 +4.89 (+0.71%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$696.85 -1.58 (-0.23%)

As of 08/1/2025 07:59 PM Eastern

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time